TRPM2 and breast adenocarcinoma: However, in both MCF-7 and MDA-MB-231 breast adenocarcinoma cells, RNAi silencing of TRPM2 led to increased amounts of cells with comets as compared to cells transfected with negative control scrambled siRNA oligos (Fig. 5A-c and A-d).